Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Lumbosacral Radicular Pain Market Size, Value And Growth Trajectory Through 2030
The lumbosacral radicular pain market has witnessed strong expansion in recent years. It is projected to increase from $0.97 billion in 2025 to $1.02 billion in 2026, registering a compound annual growth rate (CAGR) of 6.0%. The historical growth of this market can be linked to elements like an aging population, the prevalence of spinal degenerative disorders, the approach of opioid-based pain management, the establishment of hospital pain clinics, and the rising volumes of orthopedic surgeries.
The lumbosacral radicular pain market size is anticipated to undergo significant growth in the upcoming years. It is projected to achieve a value of $1.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.7%. This expansion during the forecast period can be ascribed to elements such as the embrace of non-opioid pain therapy, the increase in outpatient pain procedures, the emergence of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the broadening of rehabilitation programs. Prominent trends within the forecast timeframe encompass the rising utilization of multimodal pain management, the expansion of interventional spine procedures, an elevated demand for non-opioid therapies, the growth of rehabilitation-based care, and the adoption of minimally invasive pain treatments.
Get A Free Sample Report With In-Depth Market Insights:
Lumbosacral Radicular Pain Market Growth Momentum: What Factors Are Shaping Demand?
The growing occurrence of degenerative spinal conditions is anticipated to drive expansion in the lumbosacral radicular pain market. These conditions encompass various disorders resulting from the progressive deterioration of the spine over time. The increase in degenerative spinal conditions stems from an aging global population and lifestyle choices that heighten the likelihood of spinal degradation and nerve compression, consequently boosting the need for diagnostic and therapeutic interventions. Lumbosacral radicular pain serves as an indicator of underlying degenerative spinal issues by signaling irritation or compression of nerve roots, thereby guiding clinical assessments and treatment strategies. For example, the University of Sydney, an Australian public university, reported in May 2023 an expectation that over 800 million individuals globally will experience back discomfort by the year 2050. This surge in degenerative spinal conditions is, therefore, a key factor propelling the growth of the lumbosacral radicular pain market.
Lumbosacral Radicular Pain Market Segmentation And Category Overview
The lumbosacral radicular pain market covered in this report is segmented –
1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures
2) By Route Of Administration: Oral, Topical, Injectable, Implantable
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings
Subsegments:
1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids
2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy
3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems
Lumbosacral Radicular Pain Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc
View The Full Lumbosacral Radicular Pain Market Report:
Lumbosacral Radicular Pain Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model